Published in AIDS on April 30, 2004
Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine. Am J Pathol (2008) 0.92
Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices. Eur J Clin Nutr (2007) 0.84
Computational (DFT and TD DFT) study of the electron structure of the tautomers/conformers of uridine and deoxyuridine and the processes of intramolecular proton transfers. J Mol Model (2009) 0.80
Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement. PLoS One (2011) 0.79
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis (2010) 2.71
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology (2006) 2.62
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C. Hepatology (2012) 1.97
Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C. J Hepatol (2011) 1.55
HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high. PLoS One (2011) 1.45
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group. Arthritis Res Ther (2012) 1.44
Detection of alterations in brain glucose metabolism by positron emission tomography in Takayasu's arteritis. Eur J Nucl Med Mol Imaging (2004) 1.41
Mitochondrial DNA and sperm quality in patients under antiretroviral therapy. AIDS (2003) 1.38
Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation (2003) 1.36
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther (2007) 1.35
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens. J Antimicrob Chemother (2011) 1.26
Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Antivir Ther (2007) 1.26
Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations. Arch Neurol (2006) 1.22
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis (2012) 1.21
Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats. J Acquir Immune Defic Syndr (2009) 1.21
Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin. J Pathol (2005) 1.17
Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection. AIDS (2004) 1.17
Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies. Mitochondrion (2004) 1.16
Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans. J Immunol (2011) 1.14
Role of mtDNA lesions in anthracycline cardiotoxicity. Cardiovasc Toxicol (2007) 1.14
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging (2011) 1.12
Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial. Antivir Ther (2007) 1.09
Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors. Med Mycol (2011) 1.07
Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res Ther (2014) 1.07
Relevance of timing for determination of posaconazole plasma concentrations. Antimicrob Agents Chemother (2011) 1.05
Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis. Nephrol Dial Transplant (2004) 1.04
The role of therapeutic drug monitoring in the management of patients with human immunodeficiency virus infection. Ther Drug Monit (2011) 1.02
The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. AIDS (2004) 1.02
Clinical management of drug-drug interactions in HCV therapy: challenges and solutions. J Hepatol (2012) 0.99
Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice. Hepatology (2007) 0.97
Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis (2010) 0.96
Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study. J Clin Virol (2003) 0.96
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy. HIV Clin Trials (2008) 0.96
Effects of of didanosine-related depletion of mtDNA in human T lymphocytes. J Infect Dis (2005) 0.95
Uridine pharmacokinetics of mitocnol, a sugar cane extract. AIDS (2005) 0.94
Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy. Diabetes (2011) 0.94
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks. Gastroenterology (2011) 0.94
Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens. J Acquir Immune Defic Syndr (2005) 0.93
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients. Hepatology (2009) 0.92
Linguatuliasis in Germany. Emerg Infect Dis (2006) 0.92
Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine. Am J Pathol (2008) 0.92
Hepatitis E and jaundice in an HIV-positive pregnant woman. AIDS (2008) 0.91
The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection. J Gastroenterol (2011) 0.90
Comparison of efavirenz and nevirapine in HIV-infected patients (NEEF Cohort). Int J STD AIDS (2005) 0.90
Simultaneous determination of voriconazole and posaconazole concentrations in human plasma by high-performance liquid chromatography. Antimicrob Agents Chemother (2009) 0.90
Mitochondrial disease in the offspring as a result of antiretroviral therapy. Expert Opin Drug Saf (2006) 0.89
Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database. Rheumatology (Oxford) (2012) 0.88
Multisegmental spondylitis due to Tropheryma whipplei: case report. Orphanet J Rare Dis (2009) 0.86
Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy. Antivir Ther (2009) 0.86
Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. AIDS (2010) 0.86
Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome. PLoS One (2010) 0.85
Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry. Orphanet J Rare Dis (2013) 0.85
Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes. Antivir Ther (2005) 0.84
Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy. Arthritis Res Ther (2012) 0.84
Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol (2013) 0.83
More about masitinib. Arthritis Res Ther (2009) 0.83
Registries in systemic sclerosis: a worldwide experience. Rheumatology (Oxford) (2011) 0.83
Correlation of muscle BOLD MRI with transcutaneous oxygen pressure for assessing microcirculation in patients with systemic sclerosis. J Magn Reson Imaging (2013) 0.83
Plasma concentrations of efavirenz and nevirapine among HIV-infected patients with immunological failure attending a tertiary hospital in North-western Tanzania. PLoS One (2013) 0.82
Uridine excess does not interfere with the antiretroviral efficacy of nucleoside analogue reverse transcriptase inhibitors. Antivir Ther (2003) 0.82
Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey. Mitochondrion (2011) 0.82
Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice. Arthritis Rheum (2008) 0.82
High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid. Cancer Chemother Pharmacol (2010) 0.82
Electrocardiographic spatial QRS-T angle and incident cardiovascular disease in HIV-infected patients (from the Strategies for the Management of Antiretroviral Therapy [SMART] study). Am J Cardiol (2012) 0.81
Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behcet's disease following 23-valent polysaccharide Streptococcus pneumoniae vaccine. Rheumatology (Oxford) (2011) 0.81
Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection. J Hepatol (2008) 0.80
MRI in psoriatic arthritis with hand and foot involvement. Rheumatol Int (2006) 0.80
Hepatic steatosis with stavudine in HIV/hepatitis C virus co-infection. AIDS (2005) 0.80
The 6-maleimidocaproyl hydrazone derivative of doxorubicin (DOXO-EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage. Int J Cancer (2007) 0.80
Late-onset systemic sclerosis--a systematic survey of the EULAR scleroderma trials and research group database. Rheumatology (Oxford) (2010) 0.80
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. Ann Rheum Dis (2012) 0.80
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research. Ann Rheum Dis (2011) 0.80
Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis. Swiss Med Wkly (2010) 0.79
Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues. AIDS (2010) 0.79
Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement. PLoS One (2011) 0.79
Mitochondrial DNA depletion in rat liver induced by fosalvudine tidoxil, a novel nucleoside reverse transcriptase inhibitor prodrug. Antimicrob Agents Chemother (2009) 0.79
Respiratory chain deficiency precedes the disrupted calcium homeostasis in chronic doxorubicin cardiomyopathy. Cardiovasc Pathol (2009) 0.79
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides. Autoimmunity (2013) 0.79
No influence of the P-glycoprotein polymorphisms MDR1 G2677T/A and C3435T on the virological and immunological response in treatment naïve HIV-positive patients. Ann Clin Microbiol Antimicrob (2005) 0.79
Highly sensitive gas chromatographic determination of ethanol in human urine samples. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.78
Correlation of skeletal muscle blood oxygenation level-dependent MRI and skin laser Doppler flowmetry in patients with systemic sclerosis. J Magn Reson Imaging (2013) 0.78
HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients. BMC Infect Dis (2012) 0.78
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion. Rheumatology (Oxford) (2010) 0.78
Skeletal muscle mitochondrial DNA content and aerobic metabolism in patients with antiretroviral therapy-associated lipoatrophy. J Antimicrob Chemother (2010) 0.77
Rapid determination of nevirapine in human plasma by gas chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.77
Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study. Clin Exp Rheumatol (2012) 0.77
Drug-drug interactions in the treatment of HCV among people who inject drugs. Clin Infect Dis (2013) 0.77
Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children. Pediatr Infect Dis J (2013) 0.77